$72.6B
$52.1 Million
0.01% of portfolio
219
Q2 2024
Reduced 16.41%
$63.5B
$79.3 Million
0.01% of portfolio
2,735
Q2 2024
Reduced 12.11%
$0
$65.3 Million
0.01% of portfolio
424
Q2 2024
Reduced 15.87%
-
$35.6 Million
0.01% of portfolio
-
Q2 2024
New
$52.3B
$32.5 Million
0.01% of portfolio
370
Q2 2024
Reduced 26.73%
$66.6B
$69.2 Million
0.01% of portfolio
268
Q2 2024
Reduced 45.08%
$334B
$33.8 Million
0.01% of portfolio
33
Q2 2024
Added 106.25%
$7.12B
$40.8 Million
0.01% of portfolio
969
Q2 2024
Added 88.52%
$1.06B
$35.2 Million
0.01% of portfolio
1,202
Q4 2023
New
$0
$39.8 Million
0.01% of portfolio
846
Q2 2024
Reduced 39.74%
$12.4B
$41.1 Million
0.01% of portfolio
769
Q2 2024
Reduced 31.09%
$0
$68 Million
0.01% of portfolio
863
Q2 2024
Added 54.11%
$41.2B
$77.2 Million
0.01% of portfolio
836
Q2 2024
Added 24.96%
$0
$76.3 Million
0.01% of portfolio
1,744
Q2 2024
Reduced 51.66%
$31.5B
$31.2 Million
0.01% of portfolio
151
Q2 2024
Added 1,158.33%
$1.08B
$50.9 Million
0.01% of portfolio
5,233
Q2 2024
Added 16.7%
$108B
$51.3 Million
0.01% of portfolio
1,234
Q2 2024
Reduced 23.26%
$67.3B
$78.8 Million
0.01% of portfolio
1,249
Q2 2024
Added 0.56%
$1.47B
$37.2 Million
0.01% of portfolio
776
Q2 2024
Reduced 31.08%
$3.52B
$49.8 Million
0.01% of portfolio
2,143
Q2 2024
Reduced 62.82%
$148M
$30.8 Million
0.01% of portfolio
537
Q2 2024
Reduced 82.89%
$66.1B
$41 Million
0.01% of portfolio
291
Q2 2024
Added 49.23%
$38.8B
$38.1 Million
0.01% of portfolio
719
Q2 2024
Added 118.54%
-
$36.7 Million
0.01% of portfolio
-
Q2 2024
Reduced 61.27%
$117B
$86.6 Million
0.01% of portfolio
247
Q2 2024
Added 15.96%
$0
$63.4 Million
0.01% of portfolio
2,239
Q2 2024
Reduced 69.15%
$1.02B
$38.1 Million
0.01% of portfolio
599
Q4 2023
New
$36.2B
$43.6 Million
0.01% of portfolio
1,241
Q2 2024
Added 2,854.76%
$3.67B
$56.5 Million
0.01% of portfolio
451
Q2 2024
Reduced 19.03%
$80.6B
$37.3 Million
0.01% of portfolio
632
Q2 2024
Reduced 23.49%
$414M
$48.1 Million
0.01% of portfolio
2,386
Q2 2024
Reduced 67.22%
-
$62.2 Million
0.01% of portfolio
-
Q4 2023
Added 4,930.93%
$1.4B
$73.4 Million
0.01% of portfolio
1,218
Q2 2024
Reduced 91.3%
$1.64B
$34 Million
0.01% of portfolio
686
Q4 2023
New
$170B
$88.2 Million
0.01% of portfolio
195
Q2 2024
Added 9,650.0%
Glaxosmithkline Adr Sponsored
-
$41 Million
0.01% of portfolio
-
Q2 2024
Reduced 42.59%
$2.11B
$31.8 Million
0.01% of portfolio
274
Q2 2024
Added 0.37%
$5.81B
$36.9 Million
0.01% of portfolio
3,865
Q2 2024
Reduced 33.17%
$38.7B
$33.3 Million
0.01% of portfolio
494
Q2 2024
Added 1,443.75%
$203B
$55.1 Million
0.01% of portfolio
238
Q2 2024
Added 13.88%
$5.52B
$40.3 Million
0.01% of portfolio
374
Q2 2024
Added 85.15%
$120B
$75.3 Million
0.01% of portfolio
1,187
Q2 2024
Reduced 57.91%
$15.6B
$46 Million
0.01% of portfolio
1,617
Q2 2024
New
$24.2B
$48.5 Million
0.01% of portfolio
294
Q2 2024
Reduced 44.32%
$38.3B
$38.5 Million
0.01% of portfolio
1,082
Q2 2024
Added 221.07%
$733M
$44.5 Million
0.01% of portfolio
2,043
Q2 2024
Added 71.68%
$0
$47.4 Million
0.01% of portfolio
2,298
Q4 2023
Added 2,702.44%
$0
$40.2 Million
0.01% of portfolio
669
Q2 2024
Added 167.6%
Yield Max Dis Option Income Strategy ETF
-
$34 Million
0.01% of portfolio
-
Q2 2024
New
$7.52B
$74.2 Million
0.01% of portfolio
1,045
Q4 2023
New